Genes Chromosomes and Cancer · 1993 · 83 citations · 17 references
MedicineGeneticsOncologyCancer GeneticsMolecular OncologyNeoplasiaGerm Cell TumorsGermline Cancer PredispositionGermline Cancer SusceptibilityGermline Variant AnalysisOncogene MutationsTesticular CancerCancer Mutation AnalysisGel ElectrophoresisGermline Mutation AnalysisGermline MutationsSomatic Mutation AnalysisSomatic MutationsTp53 MutationsTumor Mutation Analysis
Mutations in the TP53 gene are considered to be among the most common genetic alterations in human cancers. Both somatic and germline mutations have been found. Using polymerase chain reaction (PCR), constant denaturant gel electrophoresis (CDGE), and denaturing gradient gel electrophoresis (DGGE), we have examined 32 patients with bilateral and familial germ cell tumors (GCT) and two patients with sporadic GCT for germline mutations within the conserved regions of the gene. In addition, 15 tumors were screened for somatic mutations and analyzed for loss of heterozygosity (LOH) at the TP53 locus. Twelve tumors were analyzed for expression of TP53 via immunohistochemistry. Neither germline nor somatic TP53 mutations were detected. LOH was observed in one of five informative cases. No tumors showed increased expression of TP53 protein. These results indicate that alterations in the TP53 gene are not important for the predisposition to and development of GCT.
17
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
Lawrence A. Donehower, Michele Harvey, Betty L. Slagle et al. · Nature · 1992 · 4.7K citations
Germ Line p53 Mutations in a Familial Syndrome of Breast Cancer, Sarcomas, and Other Neoplasms
David Malkin, Frederick P. Li, Louise C. Strong et al. · Science · 1990 · 3.8K citations
Life Sciences, Genetics, Oncology +17
Su-Ming Hsu, Laurence Raine, Herbert Fanger · American Journal of Clinical Pathology · 1981 · 1.7K citations
Medicine, Endocrinology, Pathology +11